AMAG Pharmaceuticals Inc. | Balance Sheet
Fiscal year is January-December. All values USD Millions.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
217
144
466
579
329
394
Total Accounts Receivable
7
43
86
92
104
85
Inventories
17
41
41
37
37
27
Other Current Assets
3
47
14
10
12
19
Total Current Assets
244
274
607
719
482
525
Net Property, Plant & Equipment
2
2
29
24
26
8
Total Investments and Advances
-
2
3
3
1
-
Intangible Assets
17
1,094
1,836
1,732
1,344
640
Other Assets
2
17
2
1
1
1
Total Assets
265
1,389
2,476
2,478
1,853
1,175
ST Debt & Current Portion LT Debt
-
34
18
21
-
Accounts Payable
3
7
5
4
10
Income Tax Payable
-
2
-
-
-
Other Current Liabilities
30
123
224
288
267
Total Current Liabilities
33
166
246
313
278
Long-Term Debt
-
461
974
965
735
Provision for Risks & Charges
-
218
126
51
-
Deferred Taxes
-
78
189
197
24
Other Liabilities
60
6
9
18
27
Total Liabilities
93
929
1,544
1,544
1,063
Common Equity (Total)
172
460
932
934
790
Total Shareholders' Equity
172
460
932
934
790
Total Equity
172
460
932
934
790
Liabilities & Shareholders' Equity
265
1,389
2,476
2,478
1,853
About AMAG Pharmaceuticals
View Profile
